Holistic Study of Monoclonal Antibody Upstream Technologies

Holistic Study of Monoclonal Antibody Upstream Technologies

Self Learning at Your Own Pace

This course will provide you with the necessary understanding on mAbs, the various steps of upstream processing (USP) covering process development and scale-up, production and analytics.

It includes:

  • Mix of self-paced and instructional units with 5-6 hours of learning per week (55 – 60 hours in total) over 2.5-3 months
  • Interactive collaborative platform to facilitate knowledge exchange
  • Limited synchronous activities allow participation from across the globe
icon-calendar

Duration:

40 - 50 h

Self-Learning Program Available From:

Registration is open. Register your interest by filling out the form at the bottom of this page.

icon-people
Who Should Attend

Lab managers, team leads, researchers, engineers and scientists with expertise in bioprocessing and basic knowledge of mAbs. Fluent English is essential for optimal learning.

icon-thinking
What You Will Learn

Upon completion of this course, you will understand the various steps involved in upstream processing of mAbs.

icon-coach
How You Will Learn

This online course consists self-paced allowing you to fit in learning around your work schedule. Each chapter includes assignments, access to experts using an interactive and collaborative platform to facilitate knowledge exchange between participants.

Focus Topics & Agenda

How is the Sartorius Academy's Holistic Study of Monoclonal Antibody Upstream Technologies course structured?

Kick-off

Introduction

QbD and Process Characterization

Media, Clone, and Cell Line Development

Process Development

Upstream Processing of mAbs
PAT (Analytics)

Wrap-up


Learning Modules

Introduction

  • Antibodies – fundamentals 
  • Antibodies – trends, applications, milestones 
  • Biotech product life cycle  
  • Biotech industry landscape 
  • Biopharma regulatory landscape  
  • Biologics market landscape 
  • Typical mAbs manufacturing platform 
  • What is upstream processing 

QbD and Process Characterization

  • Identify TPP/QTPP
  • Risk assessment 
  • Design space
  • Control strategy
  • Product life cycle management

Media, Clone, and Cell Line development

  • Cell line development- overview 
  • Media characterization  
  • CLD trends  


Process Development

  • Upstream process development considerations 
  • Overview of different mAb processes 
  • Cell culture optimization 
  • Process optimization


Upstream processing of mAbs

  • Seed Train  and its considerations  
  • Production modes 
  • Objectives and challenges of upstream  manufacturing


PAT (Analytics)

  • mAbs Quality assessment
  • Analytical testing  
    • Development  
    • Manufacturing


Register Your Interest

Explore

mAbs

Discover end-to-end solutions for monoclonal antibody production, from early process development to commercial manufacturing.

Learn More
scientists working in lab

Biologics Testing

From discovery to commercial manufacturing, a Complete Biologics Testing Service Helps Drug Developers and Commercial Biologics Manufacturers.

Learn More
Microbiological Quality Control

Microbiological Quality Control

Our microbiological QC portfolio is designed to give you the best tools to meet the challenges you face day to day.

Learn More